Key Aspects of Analytical Development MasterClass - US edition

18-19 February, 2025

Key elements for a successful development of a drug product analytical development

Key Aspects of Analytical Development MasterClass - US edition

The analytical aspects of the control strategy will be covered as well analytical documents for the submission.

18-19 February, 2025, Virtual
Starting time: Eastern Standard Time (EST) - UTC05:00

GET THE AGENDA NOW

 

Overview

 

The field of analytical development as part of the development of a new or generic drug product covers a huge range from the translation of the Quality Target Product Profile (QTPP) into the Analytical Target Profile (ATP) over the entire analytical procedure life cycle (i.e., development, validation, transfer, and maintenance of new analytical procedures) to key contribution to the control strategy of the commercial product (including definition of Critical Quality Attributes (CQAs), establishing of specification and justification for specification). In addition to these key elements for a successful development of a drug product analytical development is a key player in the stability studies and for the definition of the shelf-life of the medicinal product. Several regulatory documents are around analytical development which provide guidance to the key elements of this CMC topic such as the ICH guidelines for Pharmaceutical Development (Q8 (R2)), Analytical Development (Q14), Method Validation (Q2 (R2)), Specification (Q6A & Q6B), Impurities of new drug substances and products (Q3A & Q3B), and Stability testing (Q1A to Q1E). In addition, further scientific information can be found in pharmacopeial general chapters of the USP. These guidance documents form the basis of this course around analytical development. In detail, the focus of this course is on the specification of drug substances and products and their justification, determination of Critical Quality Attributes (CQAs), the life cycle of analytical procedures, analytical documentation in terms of procedure content, and validation/transfer of methods, and stability studies for drug substances and products.

Furthermore, the analytical aspects of the control strategy will be covered as well as analytical documents for the submission.

 

#masterclass #glceurope #pharmaonlinetraining #globalleadingconferences #keyaspects #analyticaldevelopment

Who should attend imgRECOMMENDATION

Who should attend?


-Analytical Development
-Formulation Development
-Project Management
-Pre-clinical Development
-Clinical Development
-CMC Regulatory Affairs
-Quality Control
-Quality Assurance
-Drug Substance Manufacture
-Drug Product Manufacture

Testimonial

Our success stories

"High attention to detail in course content and very well delivered"

Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom

Our success stories

"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"

Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland

Our success stories

"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"

Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany

About GLC

Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today its an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.

know more >

13+

Years of experience

500+

Events organized

3,970

Speakers

23,714

Attendees

REQUEST AGENDA FORM
Download Full Agenda
Get the agenda now for Additional information, Detailed program and Pricing

Name
Corporate email
Corporate phone
From where did you hear about the event?
Name of the GLC Representative (optional)
10+ participants interested from my team
E-mail consent
Privacy Policy

Other events you may like

Navigating Due Diligence in MedTech: A MasterClass for Success - EU edition

Navigating Due Diligence in MedTech: A MasterClass for Success - EU edition

18-19 November, 2024

From regulatory compliance to technical innovation, from financial scrutiny to operational efficiency

Impurities MasterClass - EU edition

Impurities MasterClass - EU edition

18-19 November, 2024

Current developments for impurities in small molecule APIs and respective medicinal products

13+

Years of experience

500+

Events organized

3,970

Speakers

23,714

Attendees

Youre in good company

deutsche bank logo e on logo kpmg logo merck logo roche logo siemens logo

Testimonial

Our success stories

"High attention to detail in course content and very well delivered"

Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom

Our success stories

"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"

Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland

Our success stories

"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"

Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany